RADNOR, Pa., May 18, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE:
AVTR) ("Avantor" or the "Company"), a leading global provider of
mission critical products and services to customers in the life
sciences and advanced technologies & applied materials
industries, today announced that certain of its stockholders (the
"Selling Stockholders") intend to offer for sale in an underwritten
secondary offering 45,000,000 shares of common stock of the Company
pursuant to a registration statement filed by the Company with the
U.S. Securities and Exchange Commission (the "SEC"). The Selling
Stockholders expect to grant the underwriters a 30-day option to
purchase up to an additional 6,750,000 shares of common stock on
the same terms and conditions. No shares are being sold by the
Company. The Selling Stockholders will receive all of the proceeds
from this offering.
Goldman Sachs & Co. LLC and J.P. Morgan are serving as the
joint book-running managers and as representatives of the
underwriters for the offering.
A registration statement, including a prospectus, which is
preliminary and subject to completion, relating to this offering
has been filed with the SEC but has not yet become effective. These
securities may not be sold nor may offers to buy be accepted prior
to the time the registration statement becomes effective. This
press release does not constitute an offer to sell or the
solicitation of an offer to buy securities, and shall not
constitute an offer, solicitation or sale in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of that
jurisdiction.
The offering of these securities will be made only by means of a
prospectus. Copies of the preliminary prospectus may be obtained
from: Goldman Sachs & Co. LLC, Attention: Prospectus Department
at 200 West Street, New York, NY
10282 or by telephone at 1-866-471-2526; or J.P. Morgan Securities
LLC, Attention: Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewood, NY 11717, by
telephone 1-866-803-9204 or by email at
prospectus-eq_fi@jpmchase.com.
About Avantor
Avantor® is
a leading global provider of mission critical products and services
to customers in the biopharma, healthcare, education &
government, and advanced technologies & applied materials
industries. We operate in more than 30 countries and deliver an
extensive portfolio of products and services. We set science in
motion to create a better world. For information,
visit www.avantorsciences.com.
Forward-Looking and Cautionary Statements
This press release contains forward-looking statements. All
statements other than statements of historical fact included in
this press release are forward-looking statements. Forward-looking
statements discuss our current expectations and projections
relating to our financial condition, results of operations, plans,
objectives, future performance and business. These statements may
be preceded by, followed by or include the words "aim,"
"anticipate," "believe," "estimate," "expect," "forecast,"
"intend," "likely," "outlook," "plan," "potential," "project,"
"projection," "seek," "can," "could," "may," "should," "would,"
"will," the negatives thereof and other words and terms of similar
meaning.
Forward-looking statements are inherently subject to risks,
uncertainties and assumptions; they are not guarantees of
performance. You should not place undue reliance on these
statements. We have based these forward-looking statements on our
current expectations and projections about future events. Although
we believe that our assumptions made in connection with the
forward-looking statements are reasonable, we cannot assure you
that the assumptions and expectations will prove to be correct.
Factors that could contribute to these risks, uncertainties and
assumptions include, but are not limited to, the factors described
in "Risk Factors" in our most recent Annual Report on Form 10-K and
Quarterly Report on Form 10-Q, as such risk factors may be updated
from time to time in our periodic filings with the SEC.
All forward-looking statements attributable to us or persons
acting on our behalf are expressly qualified in their entirety by
the foregoing cautionary statements. In addition, all
forward-looking statements speak only as of the date of this press
release. We undertake no obligations to update or revise publicly
any forward-looking statements, whether as a result of new
information, future events or otherwise other than as required
under the federal securities laws.
Global Media Contact
Allison
Hosak
Senior Vice President, Global Communications
Avantor
+1 908-329-7281
Allison.Hosak@avantorsciences.com
Investor Relations Contact
Tommy J. Thomas, CPA
Vice President, Investor Relations
Avantor
+1 781-375-8051
Tommy.Thomas@avantorsciences.com
SOURCE Avantor and Financial New
View original
content:http://www.prnewswire.com/news-releases/avantor-announces-secondary-offering-of-45-000-000-shares-of-common-stock-301061106.html
SOURCE Avantor and Financial News